My Reports
RGCIRC, Niti Bagh
Uterine Cancer Treatment
Uterine cancer is one of the most common gynaecologic cancers affecting women, yet many symptoms such as abnormal bleeding or pelvic discomfort are often overlooked, ignored, or mistaken for routine hormonal changes. Moreover, many women feel uncomfortable in discussing these symptoms, which leads to delayed diagnosis. Early diagnosis, however, is extremely important, as it can make a significant difference in treatment outcomes and long-term recovery. With advances in modern diagnostics, minimally invasive surgery, precision therapies, and personalized cancer care, uterine cancer is increasingly treatable when identified in time. At Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), we provide comprehensive multidisciplinary care for uterine cancer, focused on accurate diagnosis and advanced, patient-centric treatment protocols, supporting patients through every stage of their treatment journey.
What is Uterine Cancer?
Uterine cancer is a type of cancer that develops in the tissues of the uterus, a hollow muscular organ in the female reproductive system where a baby grows during pregnancy. Most uterine cancers begin in the inner lining of the uterus, known as the endometrium, and are therefore referred to as endometrial cancer. Less commonly, cancer may develop in the muscles or supporting tissues of the uterus, which is known as uterine sarcoma. While it is more commonly diagnosed after menopause, it can also occur in younger women, particularly in the presence of certain hormonal, genetic, or lifestyle-related risk factors. In all cases, early recognition of symptoms and timely evaluation are extremely important.
Why Early Detection of Uterine Cancer Matters
Early detection plays a crucial role in the successful treatment of uterine cancer. In many women, the disease develops slowly and may present with early warning signs such as abnormal vaginal bleeding, spotting after menopause, or changes in menstrual patterns. Recognizing these symptoms early and seeking prompt medical attention can help identify the cancer before it spreads beyond the uterus.
When diagnosed at an early stage, uterine cancer is often highly treatable, with better chances of successful treatment and lower risk of complications. Early-stage disease may also allow for less extensive treatment and improved preservation of overall quality of life. Delayed diagnosis, on the other hand, can allow the cancer to progress to nearby organs or distant parts of the body, making treatment more complex. Awareness, regular gynaecological evaluation, and timely investigation of unusual symptoms therefore remain essential for improving outcomes.
Types of Uterine Cancer
Uterine cancer is not a single disease but a group of cancers that can arise from different tissues within the uterus. Identifying the exact type of uterine cancer is important because treatment approaches and outcomes may vary.
Endometrial Cancer
Endometrial cancer is the most common type of uterine cancer and begins in the inner lining of the uterus, known as the endometrium. It is often associated with hormonal imbalance, particularly excess oestrogen exposure, and is commonly diagnosed after menopause. Many cases are detected early because abnormal bleeding usually appears as an early symptom.
Uterine Sarcoma
Uterine sarcoma is a rare and more aggressive form of uterine cancer that develops in the muscles or connective tissues of the uterus. Compared to endometrial cancer, uterine sarcomas tend to grow and spread more rapidly, often requiring more intensive treatment.
Clear Cell & Serous Carcinoma (This is a subtype of endometrial cancer)
These are less common but more aggressive subtypes of endometrial cancer. They are often associated with a higher risk of recurrence and may require a combination of surgery, chemotherapy, and radiation therapy as part of treatment.
Rare and Aggressive Uterine Tumours
Certain uncommon uterine tumours may behave differently from typical endometrial cancers and often require specialized treatment planning. Accurate diagnosis through advanced pathology plays an important role in guiding personalized care for these complex cases.
No matter what the cancer type, at RGCIRC, every case is evaluated through a multidisciplinary approach to ensure accurate diagnosis, personalized treatment planning, and advanced cancer care tailored to each patient’s condition and long-term well-being.
Signs and Symptoms of Uterine Cancer
Uterine cancer often presents with symptoms at an early stage, which is why paying attention to abnormal gynaecological changes is extremely important. While some symptoms may appear mild or be mistaken for hormonal changes, persistent or unusual bleeding and pelvic symptoms should always be medically evaluated.
Postmenopausal Bleeding
Bleeding or spotting after menopause is one of the most important warning signs of uterine cancer and should never be ignored, even if it occurs only once.
Heavy or Irregular Periods
Women may experience unusually heavy menstrual bleeding, prolonged periods, or menstrual cycles that become increasingly irregular over time.
Bleeding Between Periods
Unexpected vaginal bleeding or spotting between menstrual cycles can sometimes indicate abnormal changes within the uterus.
Pelvic Pain or Pressure
Persistent pelvic discomfort, pressure, or cramping may occur as the disease progresses and should be evaluated if symptoms continue.
Abnormal Vaginal Discharge
Watery, blood-tinged, or unusual vaginal discharge, especially after menopause, may be associated with uterine abnormalities and requires medical attention.
Unexplained Weight Loss or Fatigue
In more advanced cases, women may develop unexplained weight loss, persistent fatigue, weakness, or reduced appetite.
If any of the aforementioned symptoms appear and persist, consult a specialist as soon as possible. The earlier the intervention, the better the outcomes.
What Causes Uterine Cancer?
Although the exact cause of uterine cancer is not always known, several factors are known to be associated with abnormal growth of cells in the uterus, particularly the endometrium. These include:
Hormonal Imbalance
Changes in the balance of female hormones can stimulate excessive growth of the uterine lining, increasing the likelihood of abnormal cell changes over time.
Excess Oestrogen Exposure
Conditions or treatments that increase oestrogen exposure without progesterone support may raise the risk of endometrial cancer. This can include certain hormone therapies and menstrual or reproductive factors.
Obesity
Excess body weight is one of the most significant risk factors for uterine cancer because fat tissue can increase oestrogen production, particularly after menopause.
Diabetes
Women with diabetes may have a higher risk of uterine cancer, especially when associated with obesity and metabolic syndrome.
Genetic Syndromes (Lynch Syndrome)
Inherited genetic conditions such as Lynch syndrome significantly increase the risk of endometrial and other cancers. Women with a strong family history may require genetic counselling and closer monitoring.
Family History
A family history of uterine, ovarian, or colorectal cancer may increase risk, particularly when multiple relatives are affected.
Age and Menopause-Related Risk
Uterine cancer is more commonly diagnosed after menopause, with increasing age being an important contributing factor.
While having one or more risk factors does not necessarily mean a woman will develop uterine cancer, recognizing these associations can support earlier screening, timely evaluation, and preventive care.
Who is at Risk for Uterine Cancer?
Although uterine cancer can occur in women without any obvious risk factors, certain conditions and lifestyle-related factors may increase the likelihood of developing the disease. Understanding these risks can help women seek timely medical advice, screening, and preventive care when needed.
- Postmenopausal Women: Any abnormal bleeding after menopause requires prompt evaluation, as postmenopausal women are at higher risk for endometrial cancer.
- Obesity and Sedentary Lifestyle: Excess body weight and low physical activity can contribute to hormonal imbalance and increased oestrogen levels, raising the risk of uterine cancer.
- History of Infertility or No Pregnancies: Women who have never been pregnant or have certain reproductive health conditions may have prolonged hormonal exposure that can increase risk.
- Hormonal Therapy Risk: Long-term use of oestrogen-only hormone replacement therapy without progesterone may increase the risk of endometrial cancer.
- Family History and Inherited Mutations: Women with a family history of uterine, ovarian, or colorectal cancer, particularly those with Lynch syndrome, may have a higher genetic predisposition.
Awareness of these risk factors can support earlier diagnosis and better outcomes. Women experiencing abnormal symptoms or carrying higher-risk factors should consider timely consultation with a gynaecologic oncology specialist.
Diagnosis & Screening for Uterine Cancer
At RGCIRC, evaluation involves a combination of clinical examination, advanced imaging, pathology, and specialized diagnostic procedures to determine the type, stage, and extent of the disease.
Pelvic Examination
A pelvic examination helps the doctor assess the uterus, cervix, ovaries, and surrounding pelvic structures for any abnormalities, enlargement, or suspicious findings.
Transvaginal Ultrasound
This imaging test uses sound waves to create detailed images of the uterus and endometrial lining. It helps identify abnormal thickening, masses, or structural changes that may require further investigation.
Endometrial Biopsy
An endometrial biopsy involves collecting a small tissue sample from the lining of the uterus for microscopic examination. It is one of the most important tests for confirming endometrial cancer.
Hysteroscopy
Hysteroscopy allows doctors to examine the inside of the uterus using a thin camera-based instrument. It may also help guide targeted biopsy procedures when abnormalities are detected.
MRI & CT Scan
MRI and CT imaging help evaluate the size of the tumour, depth of invasion, and possible spread to nearby organs or lymph nodes. These scans are important for staging and treatment planning.
PET-CT Scan
In selected cases, PET-CT scans may be used to assess whether the cancer has spread beyond the pelvis.
Molecular & Genetic Testing
Advanced molecular profiling and genetic testing may help identify aggressive tumour behaviour, inherited cancer syndromes, and targeted treatment options for selected patients.
At RGCIRC, diagnostic findings are reviewed through a multidisciplinary tumour board approach to ensure personalized treatment planning and evidence-based uterine cancer care tailored to each patient’s condition.
Stages of Uterine Cancer
Staging describes how far uterine cancer has spread within the body and helps doctors determine the most appropriate treatment approach. Accurate staging is based on imaging, surgical findings, and pathological evaluation, including molecular profile of the tumor.
Stage I
At this stage, the cancer is confined to the uterus and has not spread outside it. Stage I uterine cancer is often highly treatable, especially when detected early.
Stage II
In Stage II, cancer has spread from the uterus to the cervix but remains confined to the pelvic region.
Stage III
Stage III uterine cancer indicates spread beyond the uterus and cervix to nearby tissues, lymph nodes, ovaries, or vaginal tissues within the pelvis.
Stage IV
Stage IV represents advanced disease where the cancer has spread to distant organs such as the bladder, bowel, lungs, liver, or other parts of the body.
At RGCIRC, cancer staging is carefully done through advanced imaging and pathology including comprehensive molecular profiling.
Uterine Cancer Treatment at RGCIRC
Treatment for uterine cancer depends on several factors, including the type of cancer, stage of the disease, tumour biology, overall health, and future quality-of-life considerations. At RGCIRC, uterine cancer care is delivered through a multidisciplinary approach.
Minimally Invasive & Robotic Surgery
Many women with uterine cancer may be eligible for minimally invasive or robotic-assisted surgery. These advanced surgical techniques offer greater precision and may help reduce blood loss, postoperative pain, hospital stay, and recovery time compared to conventional open surgery.
Total Hysterectomy
Surgery remains the primary treatment for many uterine cancers. A total hysterectomy involves removal of the uterus and cervix, and in some cases, the ovaries, fallopian tubes, and nearby tissues may also need to be removed depending on disease extent.
Lymph Node Assessment & Staging Surgery
Assessment of pelvic and para-aortic lymph nodes helps determine whether cancer has spread beyond the uterus. Accurate surgical staging plays an important role in guiding further treatment decisions.
Treatment after surgery depends on the post-operative histopathology report and molecular features of the removed specimen.
Radiation Therapy
Radiation therapy may be recommended after surgery or as part of treatment for advanced disease. Precision radiation techniques help to target the tumor bed while minimizing exposure to surrounding healthy tissues and organs.
Chemotherapy
Chemotherapy uses anti-cancer medicines to destroy cancer cells and may be advised in higher-stage or aggressive.
Hormone Therapy
Certain uterine cancers are hormone-sensitive and may respond to hormone-based treatments that help slow or control tumour growth. Hormone therapy may also be considered in selected younger women where fertility preservation is being evaluated.
Immunotherapy & Targeted Therapy
Advanced uterine cancers may benefit from immunotherapy or targeted therapies based on molecular and genetic tumour characteristics. These treatments aim to improve precision and treatment response in selected patients.
Advanced & Recurrent Uterine Cancer Managemen
Women with recurrent or advanced uterine cancer often require comprehensive and individualised treatment strategies involving multiple specialities. At RGCIRC, complex cases are managed through coordinated multidisciplinary care focused on disease control, symptom management, and quality of life.
Every uterine cancer treatment plan at RGCIRC is designed to combine medical excellence with compassionate support, ensuring that patients receive comprehensive care at every stage of their treatment journey.
Advanced Technology & Infrastructure at RGCIRC
Effective uterine cancer treatment requires not only clinical expertise but also advanced diagnostic and treatment infrastructure. At RGCIRC, our team leverages cutting-edge technologies designed to ensure accurate diagnosis, precise treatment delivery, improved surgical outcomes, and comprehensive supportive care throughout the treatment journey. Here are a few highlights:
Robotic & Laparoscopic Surgical Systems
Advanced robotic and minimally invasive laparoscopic surgical systems enable highly precise uterine cancer surgeries with smaller incisions, reduced blood loss, faster recovery, and shorter hospital stays. These techniques also help improve surgical accuracy while minimizing complications wherever possible.
Precision Radiation Technology
RGCIRC is equipped with advanced radiation therapy technologies that allow highly targeted treatment delivery while protecting nearby healthy organs such as the bladder and bowel. Precision planning helps improve treatment effectiveness and reduce long-term side effects.
Advanced Imaging & Diagnostics>
Modern imaging technologies including MRI, CT, PET-CT, and high-resolution ultrasound support early detection, accurate staging, and treatment planning for uterine cancer. These technologies also assist in monitoring treatment response and identifying recurrence when required.
Molecular Pathology & Genetic Testing
Advanced pathology and molecular diagnostic facilities help evaluate tumour characteristics in greater detail, supporting personalized treatment planning. Genetic testing may also help identify inherited cancer syndromes and guide targeted therapy decisions in selected patients.
Dedicated Oncology ICU & Supportive Care
Women undergoing complex surgeries, chemotherapy, or advanced cancer treatment may require specialised supportive care and monitoring. RGCIRC provides dedicated oncology critical care support, infection control measures, rehabilitation services, nutritional guidance, and psycho-oncology support to ensure comprehensive patient care.
At RGCIRC, advanced technology is integrated with multidisciplinary expertise to deliver personalized uterine cancer care focused on safety, precision, and improved long-term outcomes.
Multidisciplinary Uterine Cancer Care at RGCIRC
Uterine cancer treatment often requires expertise from multiple medical specialities working together to ensure accurate diagnosis, personalized treatment planning, and comprehensive supportive care. At RGCIRC, uterine cancer cases are managed through a multidisciplinary board that brings together specialists from various oncology disciplines to provide patient-centred care. The board includes:
Gynaecologic Oncologists
Gynaecologic oncologists play a central role in diagnosing, staging, and surgically managing uterine cancers. They work closely with other specialists to develop individualised treatment strategies based on tumour type and disease extent.
Medical Oncologists
Medical oncologists guide systemic treatments such as chemotherapy, hormone therapy, immunotherapy, and targeted therapy when required as part of multidisciplinary cancer care.
Radiation Oncologists
Radiation oncologists plan and deliver precision radiation therapy aimed at maximizing cancer control while minimizing damage to nearby healthy tissues and organs.
Onco-Pathologists & Radiologists
Specialized pathologists and radiologists help ensure accurate diagnosis, tumour classification, staging, and treatment response assessment through advanced imaging and laboratory evaluation.
Rehabilitation & Supportive Care Specialists
Recovery after cancer treatment may involve physical rehabilitation, pain management, nutritional support, and treatment of therapy related side effects. Dedicated supportive care teams help patients maintain strength, mobility, and overall well-being during treatment.
Psycho-Oncology & Nutritional Support
Cancer treatment can affect emotional health, appetite, and quality of life. Psycho-oncology experts, counsellors, and oncology nutrition specialists provide emotional support and dietary guidance to help women and families cope better throughout the treatment journey.
At RGCIRC, this collaborative approach ensures that every patient benefits from collective expertise, evidence-based decision-making, and compassionate support tailored to her medical and emotional needs.
Why to Choose RGCIRC for Uterine Cancer Treatment?
When it comes to choosing a hospital for cancer treatment, you just can’t take any chances. As a leading cancer hospital and research center in the country, RGCIRC ensures every patient has access to the care they deserve and receive the best possible outcome. Here are a few attributes that set us apart:
Comprehensive Multidisciplinary Care
From diagnosis, rehabilitation, nutrition, and emotional support, RGCIRC provides coordinated care across multiple specialities to address both medical and quality-of-life needs during treatment.
Specialised Gynaecologic Oncology Expertise
RGCIRC is supported by experienced gynaecologic oncologists and multidisciplinary oncology teams with expertise in managing both common and complex uterine cancers. Treatment strategies are carefully individualized based on tumour type, stage, and patient-specific needs.
Advanced Surgical & Radiation Technology
The institute offers access to advanced robotic surgery, minimally invasive procedures and precision radiation therapy, that help improve treatment accuracy and patient outcomes.
Personalized Treatment Planning
Every uterine cancer case is evaluated through multidisciplinary tumour board discussions involving surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists to ensure evidence-based and personalized treatment decisions.
Focus on Long-Term Survivorship & Quality of Life
Beyond cancer treatment, RGCIRC places strong emphasis on survivorship care, emotional well-being, hormonal health, rehabilitation, and long-term follow-up to help women return to healthier and more confident lives after treatment.
At RGCIRC, uterine cancer care combines advanced oncology expertise with compassionate support, ensuring that patients receive comprehensive and patient-centred care throughout their cancer journey. We understand that every woman’s cancer journey is unique and often emotionally overwhelming. But you don’t have to face it alone. Our multidisciplinary team of cancer specialists is here to ensure you receive accurate diagnosis, advanced treatment, compassionate guidance, and continuous support at every stage of care.
If you are experiencing symptoms, have concerns about abnormal bleeding, or are seeking a second opinion for uterine cancer treatment, book a consultation with the specialists at RGCIRC.
Frequently Asked Questions (FAQs)
Can uterine cancer occur before menopause?
Yes, although uterine cancer is more commonly diagnosed after menopause, younger women can also develop the disease, particularly in the presence of hormonal imbalance, obesity, genetic syndromes, or certain reproductive health conditions.
Is abnormal vaginal bleeding always a sign of uterine cancer?
Not always. Abnormal bleeding can occur due to several non-cancerous conditions such as fibroids, hormonal changes, or infections. However, persistent or postmenopausal bleeding should always be medically evaluated to rule out serious conditions, including cancer.
Can uterine cancer spread to other organs?
Yes. If left untreated, uterine cancer can spread beyond the uterus to nearby lymph nodes, ovaries, bladder, bowel, lungs, liver, or other organs. Early diagnosis significantly reduces this risk.
Is surgery necessary for all uterine cancer patients?
Surgery is the primary treatment for many cases, but treatment plans vary depending on the stage, tumour type, age, and overall health of the patient. Some women may also require chemotherapy, radiation therapy, hormone therapy, or targeted treatments.
Can uterine cancer recur after treatment?
Like many cancers, uterine cancer can recur in some patients, particularly in aggressive or advanced-stage disease. Regular follow-up and surveillance after treatment are important for early detection of recurrence.
Does uterine cancer treatment cause menopause?
In women who undergo removal of the ovaries as part of surgery, treatment may lead to surgical menopause. Doctors may discuss hormonal effects, symptom management, and supportive care before treatment planning.
How long is recovery after uterine cancer surgery?
Recovery depends on the type of surgery performed and the patient’s overall health. Minimally invasive and robotic procedures often allow faster recovery and shorter hospital stay compared to traditional open surgery.
Why is multidisciplinary care important in uterine cancer treatment?
Uterine cancer treatment often requires coordination between gynaecologic oncologists, medical oncologists, radiation specialists, radiologists, pathologists, rehabilitation experts, and supportive care teams. A multidisciplinary approach helps ensure personalized treatment decisions and comprehensive patient care.